Priti Hegde's most recent trade in Adaptimmune Therapeutics Plc - ADR was a trade of 1,144,686 Option to purchase Ordinary Shares done . Disclosure was reported to the exchange on July 1, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics P... | Priti Hegde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 1,144,686 | 1,144,686 | - | - | Option to purchase Ordinary Shares |